Body mass index and episodic headaches: A population-based study

Archives of Internal Medicine

Volumn 167, Issue 18, 2007, Pages 1964-1970

  Bigal, Marcelo E ^a,b   Tsang, Amy ^a   Loder, Elizabeth ^c   Serrano, Daniel ^d   Reed, Michael L ^d   Lipton, Richard B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^d VEDANTA RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; UNDERWEIGHT;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OBESITY; QUESTIONNAIRES; TENSION-TYPE HEADACHE;

EID: 35348935599     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.18.1964     Document Type: Article

References (25)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-657.
2. National Center for Chronic Disease Prevention and Health Promotion. Overweight and obesity: obesity trends. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index. htm. Accessed April 18, 2005.
3. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1-2):81-89.
4. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not for chronic tension-type headache. Neurology. 2006;67(2):252-257.
5. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66(4):545-550.
6. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed M, Stewart WF. Migraine prevalence, disease burden and the need of preventive therapy: migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349.
7. Diamond S, Silberstein S, Loder E, Reed M, Bigal ME, Lipton RB. Patterns of diagnosis and acute and preventive treatment of migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache. 2007;47(3):355-363.
8. Silberstein SD, Loder E, Diamond S, Reed M, Bigal ME, Lipton RB; AMPP Advisory Group. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007;27(3):220-234.
9. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6)(suppl 1):S20-S28.
10. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, ed 2. Cephalgia. 2004;24(suppl 1):1-15.
11. Barnes P, Schiller JS. Early release of selected estimates based on data from the 2006 National Health Interview Survey. National Center for Health Statistics Web site. http://www.cdc.gov/nchs/nhis.htm. Accessed July 16, 2007.
12. The obesity epidemic: fat, fact and fiction. National Institute for Medical Research Web site. http://www.nimr.mrc.ac.uk/millhillessays/2002/ obesity.htm. Accessed May 8, 2006.
13. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-1312.
14. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5(2):148-157.
15. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296(3):283-291.
16. Young WB, Rozen TD. Preventive treatment of migraine: effect on weight. Cephalalgia. 2005;25(1):1-11.
17. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache. 1998;38(2):87-96.
18. Himes JH, Hannan P, Wall M, Neumark-Sztainer D. Factors associated with errors in self-reports of stature, weight, and body mass index in Minnesota adolescents. Ann Epidemiol. 2005;15(4):272-278.
19. Schoenborn CA, Adams PF, Barnes PM. Body weight status of adults: United States, 1997-98. Adv Data. 2002;6(330):1-15.
20. Luder E, Ehrlich RI, Lou WY, Melnik TA, Kattan M. Body mass index and the risk of asthma in adults. Respir Med. 2004;98(1):29-37.
21. Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994;44(10)(suppl 7):S4-S5.
22. Bigal ME, Lipton RB, Holland P, Goadsby PJ. Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68(21):1851-1861.
23. Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH. Calcitonin gene-related peptide in human obesity. Peptides. 1991;12(4):861-863.
24. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22(12):1145-1158.
25. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005;315(3):1380-1385.